Home > Boards > US Listed > Medical - Healthcare >

China Infrastructure (CHNC)

Add CHNC Price Alert      Hide Sticky   Hide Intro
Moderator: soupoftheday, PROPHET-of-PROFITS, LOVE*PINK, HNDRXX, limitlessotc
Search This Board: 
Last Post: 11/30/2020 8:51:15 PM - Followers: 135 - Board type: Free - Posts Today: 0



Investor Relations - (817) 528-2475

On August 20, 2020, PRI was merged with and into the Company.


China Infrastructure Construction Corp. ---  Pink Current



Acquisition of Precision Research Institute, LLC

On March 31, 2019, the Company acquired all of the outstanding units in Precision Research Institute, LLC, a Texas limited liability company (“PRI”) formed on May 18, 2016, from the Company’s president.

PRI is a Multi-Therapeutic, Dedicated Research Unit based in Houston, Texas. PRI brings multi-million-dollar contracts with the largest pharmaceutical companies in the world--like Abbvie, Samumed, Gilead, Intercept, Shire Pharmaceuticals, and more. President & CEO Elizabeth Hernandez says, “This acquisition of PRI, our second in the past year, now puts CHNC in the unique position of conducting its own clinical research trials. Which holds an important value the to the future of Medicine. CHNC is now in position to be the leader in the arena of Medical Clinical Trials. CHNC is in the process of becoming its very own Contract Research Organization (CRO) in the Industry. The looking forward to developing the future of Pharmaceutical, Biotechnology, and Pharmacovigilance Clinical Trials.
PRI has Phase I, II, and III clinical trial capabilities--a rare feat.
PRI’s facility is 4500 sq. ft. and currently has ongoing Phase II, III clinical trials, along with observational studies. 
Their fifteen active multi-million-dollar contracts is a great head start for CHNC. We look forward to expanding quickly!”


The Company operates through three wholly owned subsidiaries. Through Hippocrates Direct Healthcare, LLC, a Texas limited liability company (“HDH”), formed on September 11, 2017, the Company offers concierge medicine at an affordable price through its membership-based model. Through Precision Research Institute, LLC, a Texas limited liability company (“PRI”) formed on May 18, 2016, the Company provides services in therapeutic areas of clinical trials, Through Pharmacology University, Inc., a Delaware corporation (“PUI”), incorporated on January 7, 2017, the Company provides educational systems focused on medicinal cannabis, in cities throughout the United States of America and six countries in Latin America. Information regarding the acquisition of these subsidiaries is as follows:

Acquisition of HDH and Recapitalization

On December 14, 2017, the Company, a wholly owned subsidiary of the Company and HDH entered into a Plan and Agreement of Merger (the “HDH Merger Agreement”), which provided that the subsidiary would be merged with and into HDH and that the two holders of units in HDH would receive shares of the Company’s common stock or cash, as each of them elected. On February 5, 2018 (the “Effective Date”), the merger was consummated, as the result of which HDH became the wholly owned subsidiary of the Company and the Company issued 4,500,000,000 shares of its common stock to one of the holders of units in HDH and made a promissory note for $9,500 in favor of the other, in accordance with their elections. Pursuant to the HDH Merger Agreement, the sole director, officer and majority stock-holder of the Company resigned from these positions, surrendered all of his shares of common stock in the Company and cancelled all of its indebtedness to him in consideration of a promissory note made by the Company in his favor in the principal amount of $420,000. (For information about this note, see Note 5.)

The merger whereby the Company acquired HDH was a reverse merger that resulted in a change of control, and has been accounted for as a recapitalization, whereunder HDH is the accounting acquirer. Accordingly, the historical financial statements prior to the Effective Date are those of HDH, have been prepared to give retroactive effect to the merger and represent the operations of HDH. The consolidated financial statements include the balance sheets of both companies at historical cost, the historical results of HDH and the results of the Company from the Effective Date. All share and pershare information in the accompanying unaudited consolidated financial statements and these notes has been retroactively restated to reflect the recapitalization.


Acquisition of Pharmacology University, Inc.

On December 19, 2019, the Company acquired Pharmacology University, Inc., a Delaware corporation (“PUI”), pursuant to an Agreement and Plan of Merger, dated as of November 7, 2019, under which PUI was merged with and into the Company (the “PU Merger Agreement”). Pursuant to this agreement, the Company is obligated to issue, to the former holders of the common stock of PUI, 4,875,000,000 shares of the Company’s common stock and 2,000,000 shares of its Series A Convertible Preferred Stock. These shares are expected to be issued in the near future. When the shares are issued, a change of control will occur. In a separate agreement, Ms. Elizabeth Hernandez, the holder of 4,500,000,000 shares of Common Stock, and the president, sole director and controlling stockholder of the Company agreed to sell 3,000,000,000 such shares to the Company pursuant to a Stock Purchase Agreement, dated November 7, 2019, between the Company and her (the “Hernandez SPA”).


FaceBook - https://m.facebook.com/PrecisionResearchInstituteLLC/

Twitter - https://twitter.com/pri_center?s=11

Top of page B-11 https://backend.otcmarkets.com/otcapi/company/financial-report/256967/content

Acquisition of PRi had taken place on 31 March, 2019

Acquisition of Precision Research Institute, LLC On March 31, 2019, the Company acquired all of the outstanding units in Precision Research Institute, LLC, a Texas limited liability company (“PRI”) formed on May 18, 2016, from the Company’s then president.

 Bottom of Page B-5 https://backend.otcmarkets.com/otcapi/company/financial-report/256967/content


Merger with Pharmacology University, Inc.

 Merger with Pharmacology University, Inc. On December 19, 2019, Pharmacology University, Inc., a Delaware corporation (“PUI”), with and into the Company pursuant to an Agreement and Plan of Merger, dated as of November 7, 2019, under which PUI was merged with and into the Company (the “PU Merger Agreement”).

Bottom of Page B-5 https://backend.otcmarkets.com/otcapi/company/financial-report/256967/content




Source:  https://www.otcmarkets.com/stock/CHNC/news


OTC Markets - Disclosure



Transfer Agent:

Pacific Stock Transfer Company
6725 Via Austi Parkway,
Suite 300 Las Vegas,
NV 89119
Phone: (800) 785-7782


A/S  20,000,000,000   09/30/2020

O/S    8,732,256,416   09/30/2020

Restricted 7,023,693,512   09/30/2020

Unrestricted 1,708,562,904  09/30/2020

Held at DTC   1,380,650,255    09/30/2020  

Float   1,708,562,904  05/31/2020 Page 2 Number of shares in the Public Float: 1,708,562,904 as of the end of the Reporting Period and as of the date hereof:"" rel="nofollow ugc" target="_blank">https://backend.otcmarkets.com/otcapi/company/financial-report/256967/content"; target="_blank" rel="nofollow ugc"> https://backend.otcmarkets.com/otcapi/company/financial-report/256967/content


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CHNC News: Epazz, Inc. (OTC Pink: EPAZ) - Healthcare & Government Contracts and now Education 09/22/2020 06:25:59 AM
#5382  Sticky Note CHNC COVID 19 NEWS: $CHNC Publishes Its Phytotherapy HNDRXX 11/18/20 11:21:29 AM
#4842  Sticky Note $CHNC: NO CONVERTIBLE DEBT... 0 NOTES... PROPHET-of-PROFITS 10/30/20 12:50:48 PM
#3820  Sticky Note $CHNC: DD Package PharmacologyUniversity, Merger Clinical Trials, Insider HNDRXX 10/12/20 10:45:28 PM
#2983  Sticky Note https://www.pri.center Excellent HealthCare Subsidiary. LOVING IT. LOVE*PINK 10/07/20 05:47:23 PM
#5883   This thing had days where it traded 1.5billion Prudent1 11/30/20 08:51:15 PM
#5882   Hopefully news this week since the chart is PROPHET-of-PROFITS 11/30/20 06:15:23 PM
#5881   Impatient people jumping for another runner esi23 11/30/20 03:35:40 PM
#5880   With all this triple zipper grim ripper mania Chivito 11/30/20 03:10:46 PM
#5879   will run soon HNDRXX 11/30/20 12:31:48 PM
#5878   Once PR hits, CHNC will go to .002++ Easy. primecomm 11/30/20 10:47:17 AM
#5877   yep holding for news, since none yet you koolmc 11/30/20 10:43:24 AM
#5876   single trader taking their funds elsewhere it happens. PROPHET-of-PROFITS 11/30/20 10:33:29 AM
#5875   CHNC - HUUGE dump @ .0008. Wonder why?? mperfection 11/30/20 10:30:08 AM
#5874   Strong hold on 9’s is such a positive Elpapibh 11/30/20 09:39:42 AM
#5873   My gut tells me we pop today solmer 11/30/20 08:50:04 AM
#5872   that's what i said... chnc has a lot PROPHET-of-PROFITS 11/29/20 09:59:51 PM
#5871   Its their magazine? ScottishTexan 11/29/20 08:53:59 PM
#5870   http://www.cannalawmagazine.com/ by chnc PROPHET-of-PROFITS 11/29/20 07:58:04 PM
#5869   you are looking way ahead we haven't even koolmc 11/28/20 02:20:42 PM
#5868   ceo has other things he finds more important PROPHET-of-PROFITS 11/28/20 01:43:47 PM
#5867   anyone... Bueller? ... Bueller? ChowChowDog 11/28/20 12:53:12 PM
#5866   how long does a name change take to ChowChowDog 11/27/20 06:38:55 PM
#5865   Agree. Name change needs to happen. ScottishTexan 11/27/20 04:35:56 PM
#5864   Exactly supply and demand. Less supply means the Elpapibh 11/27/20 04:23:14 PM
#5863   Imo the float is getting locked up. Supply PROPHET-of-PROFITS 11/27/20 03:36:34 PM
#5862   A close of .0009 and a high of Elpapibh 11/27/20 03:22:25 PM
#5861   We move up Monday! Vinylboyz 11/27/20 01:06:11 PM
#5860   where are 8s bids? This is one Manipulative primecomm 11/27/20 12:56:59 PM
#5859   If it can keep this level before the PROPHET-of-PROFITS 11/27/20 12:54:06 PM
#5858   The ask will fall for next week imo. Poundthetable 11/27/20 12:46:03 PM
#5857   Folks .001s might not be available on Monday. lol primecomm 11/27/20 12:30:34 PM
#5856   Let's go!!! Vinylboyz 11/27/20 12:25:14 PM
#5855   Lets close above .001++ Today! primecomm 11/27/20 12:20:17 PM
#5854   great news and this is gonna run, the koolmc 11/27/20 12:15:49 PM
#5853   Ask is shrinking. 001s will fall soon. primecomm 11/27/20 12:03:50 PM
#5852   you said It’s coming! Poundthetable 11/27/20 12:00:09 PM
#5851   .0015-.002 Pre-Market on Monday.. primecomm 11/27/20 11:51:55 AM
#5850   Need a strong bid then .001s will clear easy. primecomm 11/27/20 11:49:49 AM
#5849   What did I say????!!!! georgeofthebungle 11/27/20 11:45:43 AM
#5848   .001s hitting. Explosion Imminent $$$$$ primecomm 11/27/20 11:40:45 AM
#5847   Fake Wall at .001===>> Will get smashed soon. primecomm 11/27/20 11:34:50 AM
#5846   nice eod load for next week koolmc 11/27/20 11:33:20 AM
#5845   $CHNC READY TO EXPLODE TODAY .0015+++ primecomm 11/27/20 11:33:19 AM
#5844   will run big soon HNDRXX 11/27/20 11:32:46 AM
#5843   WOW why so many slaps? more news? Chivito 11/27/20 11:32:38 AM
#5842   .001s Up and Thin. KABOOM TIMEEEEEEEE primecomm 11/27/20 11:31:42 AM
#5841   quite the turn on L2... PROPHET-of-PROFITS 11/27/20 11:31:36 AM
#5840   9s hitting and thin folks. primecomm 11/27/20 11:31:14 AM
#5839   $CHNC Partnership with Gilead Sciences ==>> .01++++ IMO primecomm 11/27/20 10:27:23 AM
#5838   It’s coming! georgeofthebungle 11/27/20 10:24:05 AM
#5837   9s sellers moved to 8s. lol primecomm 11/27/20 10:21:41 AM
#5836   We have too many morons flippers on this primecomm 11/27/20 10:18:04 AM
#5835   .0008s starting to bid now. If we can take Lonewolf1 11/27/20 10:15:10 AM
#5834   $CHNC Whales are circling. BOOM SOON $$$$$$ primecomm 11/27/20 10:11:31 AM
Consent Preferences